共 185 条
[21]
Eiber M(1995)Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues Urol Oncol 45 2045-674
[22]
Flavell RR(2018)Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer Eur J Nucl Med Mol Imaging 197 105506-735
[23]
Mishoe A(2020)The role of adrenal derived androgens in castration resistant prostate cancer J Steroid Biochem Mol Biol 58 81-755
[24]
Feng FY(2017)68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience J Nucl Med 56 668-167
[25]
Zhou J(2015)Evaluation of hybrid (6)(8)Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy J Nucl Med 80 729-775
[26]
Gou Z(2017)Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review Cancer Chemother Pharmacol 58 750-1655
[27]
Wu R(2017)The clinical impact of additional late PET/CT imaging with (68)Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer J Nucl Med 47 160-602
[28]
Yuan Y(2020)Dynamic patterns of [(68)Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions Eur J Nucl Med Mol Imaging 44 765-291
[29]
Yu G(2017)Early dynamic imaging in (68)Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions Eur J Nucl Med Mol Imaging 44 1647-518
[30]
Zhao Y(2017)Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence Eur J Nucl Med Mol Imaging 47 592-undefined